Revenue | ₹795.50Cr |
Net Profits | ₹120.19Cr |
Net Profit Margins | 15.11% |
ERIS Lifesciences Ltd’s revenue jumped 6.68% since last year same period to ₹795.50Cr in the Q2 2025-2026. On a quarterly growth basis, ERIS Lifesciences Ltd has generated 2.44% jump in its revenue since last 3-months.
ERIS Lifesciences Ltd’s net profit jumped 31.23% since last year same period to ₹120.19Cr in the Q2 2025-2026. On a quarterly growth basis, ERIS Lifesciences Ltd has generated 1.86% jump in its net profits since last 3-months.
ERIS Lifesciences Ltd’s net profit margin jumped 23.01% since last year same period to 15.11% in the Q2 2025-2026. On a quarterly growth basis, ERIS Lifesciences Ltd has generated -0.56% fall in its net profit margins since last 3-months.
The revenue for ERIS Lifesciences Ltd in the Q2 results 2025 was ₹795.50Cr.
The net profit for ERIS Lifesciences Ltd in the Q2 results 2025 was ₹120.19Cr.
The net profit margin for ERIS Lifesciences Ltd in the Q2 results 2025 was 15.11%.
The revenue for ERIS Lifesciences Ltd in the Q2 results 2024 was ₹745.72Cr.
The net profit for ERIS Lifesciences Ltd in the Q2 results 2024 was ₹91.59Cr.
The net profit margin for ERIS Lifesciences Ltd in the Q2 results 2024 was 12.28%.